FLUCELVAX suspension injectable en seringue préremplie. Vaccin antigrippal inactivé (antigène de surface, préparé sur cultures cellulaires) — 1 seringue préremplie en verre de 0,5 mL avec aiguille

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400930304686
  • CIP7 3030468
  • CIS 62752472
  • Registration number EU/1/24/1879

What the source publishes

Holder
SEQIRUS NETHERLANDS (PAYS BAS)
Active ingredients
ANTIGÈNES DE SURFACE DU VIRUS DE LA GRIPPE, INACTIVÉ, SOUCHE A/MISSOURI/11/2025 (H1N1)PDM09-SOUCHE ANALOGUE (A/TASMANIA/318/2025, CVR-351), ANTIGÈNES DE SURFACE DU VIRUS DE LA GRIPPE, INACTIVÉ, SOUCHE B/PENNSYLVANIA/14/2025-SOUCHE ANALOGUE (B/ARIZONA/21/2025, TYPE SAUVAGE), ANTIGÈNES DE SURFACE DU VIRUS DE LA GRIPPE, INACTIVÉ, SOUCHE A/DARWIN/1415/2025 (H3N2)-SOUCHE ANALOGUE (A/TASMANIA/787/2025,…
Form
suspension injectable
Package
1 seringue préremplie en verre de 0,5 mL avec aiguille
Routes
intramusculaire
Administrative status
authorised
Supply regime
liste I
Marketing status
Déclaration de commercialisation
Authorised on
2024-11-15
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400930304686
{
  "cis": "62752472",
  "cip7": "3030468",
  "form": "suspension injectable",
  "name": "FLUCELVAX suspension injectable en seringue préremplie. Vaccin antigrippal inactivé (antigène de surface, préparé sur cultures cellulaires) — 1 seringue préremplie en verre de 0,5 mL avec aiguille",
  "cip13": "3400930304686",
  "holder": "SEQIRUS NETHERLANDS (PAYS BAS)",
  "routes": [
    "intramusculaire"
  ],
  "holders": [
    "SEQIRUS NETHERLANDS (PAYS BAS)"
  ],
  "currency": "EUR",
  "marketed": true,
  "bdmStatus": null,
  "useDomain": "unknown",
  "publicPrice": "12.77",
  "authorisedOn": "2024-11-15",
  "compositions": [
    {
      "name": "ANTIGÈNES DE SURFACE DU VIRUS DE LA GRIPPE, INACTIVÉ, SOUCHE A/MISSOURI/11/2025 (H1N1)PDM09-SOUCHE ANALOGUE (A/TASMANIA/318/2025, CVR-351)",
      "nature": "SA",
      "strength": "15 microgrammes d'hémagglutinine",
      "linkageNumber": "1",
      "substanceCode": "16835",
      "dosageReference": "une dose de 0,5 mL",
      "pharmaceuticalElement": "suspension"
    },
    {
      "name": "ANTIGÈNES DE SURFACE DU VIRUS DE LA GRIPPE, INACTIVÉ, SOUCHE B/PENNSYLVANIA/14/2025-SOUCHE ANALOGUE (B/ARIZONA/21/2025, TYPE SAUVAGE)",
      "nature": "SA",
      "strength": "15 microgrammes d'hémagglutinine",
      "linkageNumber": "3",
      "substanceCode": "65761",
      "dosageReference": "une dose de 0,5 mL",
      "pharmaceuticalElement": "suspension"
    },
    {
      "name": "ANTIGÈNES DE SURFACE DU VIRUS DE LA GRIPPE, INACTIVÉ, SOUCHE A/DARWIN/1415/2025 (H3N2)-SOUCHE ANALOGUE (A/TASMANIA/787/2025, CVR-388)",
      "nature": "SA",
      "strength": "15 microgrammes d'hémagglutinine",
      "linkageNumber": "2",
      "substanceCode": "93855",
      "dosageReference": "une dose de 0,5 mL",
      "pharmaceuticalElement": "suspension"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "liste I",
  "dispensingFee": "1.02",
  "medicinePrice": "11.75",
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "FLUCELVAX suspension injectable en seringue préremplie. Vaccin antigrippal inactivé (antigène de surface, préparé sur cultures cellulaires)",
  "marketingStatus": "Déclaration de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-11-20",
    "CIS_CIP_bdpm": "2026-11-20",
    "CIS_CPD_bdpm": "2026-11-20",
    "CIS_COMPO_bdpm": "2026-11-20"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "oui",
  "packageDescription": "1 seringue préremplie en verre de 0,5 mL avec aiguille",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [
    "65 %"
  ],
  "marketingDeclaredOn": "2025-09-01",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "authorised",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "ANTIGÈNES DE SURFACE DU VIRUS DE LA GRIPPE, INACTIVÉ, SOUCHE A/MISSOURI/11/2025 (H1N1)PDM09-SOUCHE ANALOGUE (A/TASMANIA/318/2025, CVR-351)",
    "ANTIGÈNES DE SURFACE DU VIRUS DE LA GRIPPE, INACTIVÉ, SOUCHE B/PENNSYLVANIA/14/2025-SOUCHE ANALOGUE (B/ARIZONA/21/2025, TYPE SAUVAGE)",
    "ANTIGÈNES DE SURFACE DU VIRUS DE LA GRIPPE, INACTIVÉ, SOUCHE A/DARWIN/1415/2025 (H3N2)-SOUCHE ANALOGUE (A/TASMANIA/787/2025, CVR-388)"
  ],
  "authorisationProcedure": "Procédure centralisée",
  "prescriptionConditions": [
    "liste I"
  ],
  "reimbursementIndications": null,
  "authorisationSourceStatus": "Autorisation active",
  "europeanAuthorisationNumber": "EU/1/24/1879",
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400930304686"